Skip to main content
SpringerLink
Log in

The Pattern of Infection in Immunodeficiency

  • Chapter
Immunology of Infection

Part of the book series: Immunology and Medicine Series ((IMME,volume 25))

  • 87 Accesses

Abstract

Although experiments in animals can tell us something about the mechanisms of protection against infection, the relevance to human disease is usually uncertain. The study of rare immunodeficiency disorders has enabled us to make some clear statements on the critical role of individual host defence mechanisms against infection. It is likely that new genetically determined defects in relatively minor aspects of host defence or inflammation (e.g. lymphokines) will soon be discovered and enlighten us on the efficiency of the many ‘back-up’ mechanisms for dealing with infecting organisms. The problem with many of the known severe immunodeficiency disorders, such as severe combined immunodeficiency, is that more than one cell type is involved, making it difficult to link the clinical pattern of infection with any specific defect. Furthermore, it can be difficult to locate the immune defect in patients who are chronically infected with an organism, since the infection itself may cause secondary ‘abnormalities’ in the immune system, as is seen in mucocutaneous candidiasis. Nevertheless, studies in patients with immunodeficiencies involving antibody production and neutrophil function have enabled us to link defence mechanisms to specific infections. Most of these studies have been undertaken on patients in advanced countries, and the results may not apply to individuals in the Third World who are more frequently exposed to a wider range of organisms. In this situation a relatively minor defect in an amplifying or back-up mechanism may be potentially lethal.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Levinsky RJ, Tiedeman K. Successful bone marrow transplantation for reticular dysgenesis. Lancet. 1983; I: 671–673.

    Article  Google Scholar 

  2. Perry VH, Gordon S. Macrophages and microglia in the nervous system. Trends Neurosci. 1988; 11: 273–277.

    Article  PubMed  CAS  Google Scholar 

  3. Dale DC, DuPont G, Wewerka JR, Bull JM, Chusid MJ. Chronic neutropenia. Medicine. 1979; 58: 128–144.

    Article  PubMed  CAS  Google Scholar 

  4. Medical Research Council Working Party on Leukaemia in Childhood. Analysis of treatment in childhood leukaemia. I. Prolonged predisposition to drug-induced neutropenia following craniospinal irradiation. Br Med J. 1975; 3: 563–566.

    Article  Google Scholar 

  5. Hitzig WH. Familiare neutropenie mit dominanten erbgang and hypergammaglobulinamie. Hely Med Acta. 1959; 26: 779–784.

    CAS  Google Scholar 

  6. Asherson GL, Webster ADB. Diagnosis and treatment of immunodeficiency diseases. Oxford: Blackwell Scientific, 1980: 301–302.

    Google Scholar 

  7. Segal A, Walport M. Neutrophil and complement defects: recent advances. In Webster ADB, ed. Immunodeficiency and Disease. London: Kluwer Academic Publishers, 1988: 149–179.

    Chapter  Google Scholar 

  8. Roos D. The molecular basis of chronic granulomatous disease. In: Gupta S, Griscelli C, eds. New Concepts of Immunodeficiency Diseases. Chichester: John Wiley, 1993: 311–352.

    Google Scholar 

  9. Nauseff WM, Root RK, Maleck HL. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency. J Clin Invest. 1983; 71: 1297–1307.

    Article  Google Scholar 

  10. Parry MF, Root RK, Metcalf JA, Delaney KK, Kaplow LS, Richar WT. Myeloperoxidase deficiency. Prevalence and clinical significance. Ann Intern Med. 1981; 95: 293–301.

    PubMed  CAS  Google Scholar 

  11. Root RK, Rosenthal AS, Balestra DJ. Abnormal bactericidal, metabolic and lysosomal functions of Chediak-Higashi syndrome. J Clin Invest. 1972; 51: 649–665.

    Article  PubMed  CAS  Google Scholar 

  12. Geha RS, Leung DYM. Hyper immunoglobulin E syndrome. In: Rosen FS, Seligmann M, eds Immunodeficiencies. Philadelphia, PA: Harwood Academic, 1993: 571–583.

    Google Scholar 

  13. Gallin JI, Fischer A, Lisowska-Grospierre B, Anderson DC, Springer TA. Leukocyte adhesion deficiency: molecular basis and functional consequences. Immunodeficiency Rev. 1988; 1: 38–54.

    Google Scholar 

  14. Davies KA, Toothill VJ, Savill J, Hotchin N, Peters AM, Pearson JD, Haslett C, Burke M, Law SKA, Mercer NFG, Walport MJ, Webster ADB. A 19-year-old man with leucocyte adhesion deficiency. In vitro and in vivo studies of leucocyte function. Clin Exp Immunol. 1991; 84: 223–231.

    Article  PubMed  CAS  Google Scholar 

  15. Hosea SW, Brown EJ, Hamburger MI, Frank MM. Opsonic requirements for intravascular clearance after splenectomy. N Engl J Med. 1981; 304: 245–250.

    Article  PubMed  CAS  Google Scholar 

  16. Hosea SW, Burch CG, Brown EG, Berg RA, Frank MM. Impaired immune response in splenectomised patients to polyvalent pneumococcal vaccine. Lancet. 1981; i; 804–807.

    Article  Google Scholar 

  17. Ceuppens JL, Baroja ML, van Vaek F, Anderson CL. Defect in the membrane expression of high affinity 72-kD Fcy receptors on phagocytic cells in four healthy subjects. J Clin Invest. 1988; 82: 571–578.

    Article  PubMed  CAS  Google Scholar 

  18. Bernichou G, Kanellopoulos JM, Wallow C, Bove F, Defraissy JF. Interferon-y restores T lymphocyte proliferation of non-responders to IgGI anti-CD3 via the induction of Fcy’ receptors on monocytes. Eur J Immunol. 1987; 17: 1175–1181.

    Article  Google Scholar 

  19. Qualman SJ, Gupta PK, Mendelsohn G. Intracellular Escherichia coli in urinary malakoplakia. A reservoir of infection and its therapeutic implications. Am J Clin Pathol. 1984; 81: 35–42.

    PubMed  CAS  Google Scholar 

  20. Abdou NI, Na Pombejara C, Sayawa A, Ragland C, Stechscwulte DJ, Nilsson U, Gourley W, Wattanabe I, Lindsey NJ, Allen MS. Malokoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonist in vitro and in vivo. New Engl J Med. 1977; 297: 1413–1419.

    Article  PubMed  CAS  Google Scholar 

  21. Komiyama A, Ichikawa M, Kanda H, Aoyama K, Yasui K, Yamazaki M, Kawai H, Miyagawa Y, Akabane T. Defective interleukin-1 production in a familial monocyte disorder with a combined abnormality of mobility and phagocytosis-killing. Clin Exp Immunol. 1988; 73: 500–504.

    PubMed  CAS  Google Scholar 

  22. Dobbins WO. Whipple’s disease: an historical perspective. Q J Med. 1985; 56: 523–531.

    PubMed  Google Scholar 

  23. Dobbins WO. Is there an immune deficit in Whipple’s disease? Dig Dis Sci. 1981; 26: 247–252.

    Article  PubMed  Google Scholar 

  24. Bjerknes R, Laerum OP, Oegaards S. Impaired bacterial degradation by monocytes and macrophages from a patient with treated Whipple’s disease. Gastroenterology. 1985; 89: 1139–1151.

    PubMed  CAS  Google Scholar 

  25. Feurle GH, Dörken B, Schöpf E, Lenhard V. HLA-B27 and defects in the T-cell system in Whipples disease. Eur J Clin Invest. 1979; 9: 385–389.

    Article  PubMed  CAS  Google Scholar 

  26. Nathan CF, Murray HW, Wiebe ME, Ruben BY. Identification of interferon-y as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med. 1983; 158: 670–689.

    Article  PubMed  CAS  Google Scholar 

  27. Nathan CF, Kaplan G, Levis WR, Nusra A, Witmer MD, Sherwin SA, Job CK, Horowitz CR, Steinman RM, Cohn ZA. Local and systemic effects of intradermal recombinant interferon-y in patients with lepromatous leprosy. N Engl J Med. 1986; 315: 6–15.

    Article  PubMed  CAS  Google Scholar 

  28. Denis M, Forget A, Pelletier M, Skamene E. Pleiotropic effects of the Bcg gene. III. Respiratory burst in Bcg-congenic macrophages. Clin Exp Immunol. 1988; 73: 370–375.

    PubMed  CAS  Google Scholar 

  29. Winston DJ, Terito MC, Ho WG, Miller MJ. Gale RP, Golde DW. Alveolar macrophage dysfunction in human bone marrow transplant recipients. Am J Med. 1982; 73: 859–866.

    Article  PubMed  CAS  Google Scholar 

  30. Murray HW, Rubin BY. Masur H, Roberts RB. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med. 1984; 310: 883–887.

    Article  PubMed  CAS  Google Scholar 

  31. Murray HW, Gellene RA, Libby DM, Rothermel CD, Rubin BY. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma. J Immunol. 1985; 135: 2374–2377.

    PubMed  CAS  Google Scholar 

  32. Amman AJ. Immunological aberrations in purine nucleoside phosphorylase deficiencies. In: Enzyme Defects and Immune Dysfunction. Ciba Foundation Symposium Series, 68. Amsterdam. Elsevier, 1979: 55–69.

    Google Scholar 

  33. Zegers BJM, Stoop JW. Metabolic causes of immune deficiency: mechanisms and treatment. In: Webster ADB, ed. Immunodeficiency and Disease. London: Kluwer Academic, 1988: 113–131.

    Chapter  Google Scholar 

  34. Hong R. The DiGeorge anomaly. In: Rosen FS, Seligmann M, eds. Immunodeficiencies. Philadelphia, PA: Harwood Academic, 1993: 167–176.

    Google Scholar 

  35. Barrett DJ, Amman AI, Wara DW, Cowan MJ, Fisher TJ, Stiehm ER. The clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol. 1981; 6: 1–6.

    PubMed  CAS  Google Scholar 

  36. Webster ADB. Lymphocyte disorders in immunodeficiency. In: Peters TJ, ed. Subcellular Pathology of Systemic Disease. London: Chapman and Hall Medical, 1987: 304–320.

    Google Scholar 

  37. Fisher D, Martin B, van der Weyden R, Snyderman R, Kelley WN. A role for adenosine deaminase in human monocyte maturation. J Clin Invest. 1976; 58: 399–407.

    Article  Google Scholar 

  38. Morgan G, Levinsky RJ, Hugh-Jones K, Fairbanks LD, Morris GS, Simmonds A. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency. Clin Exp Immunol. 1987; 70: 491–499.

    PubMed  CAS  Google Scholar 

  39. Griscelli C, Lisowska-Grospierre B. Combined immunodeficiency with defective expression in MHC class II genes. In: Gupta S, Griscelli C, eds. New Concepts of Immunodeficiency Diseases. Chichester: John Wiley, 1993: 177–190.

    Google Scholar 

  40. Noguchi M, Rosenblatt HM, Adelstein S, McBride OW, Leonard WJ. Interleukin-2 receptor y chain mutation results in X-linked severe combined immunodeficiency in humans. Cell. 1993; 73: 147–157.

    Article  PubMed  CAS  Google Scholar 

  41. Fischer A, Griscelli C, Friedrich W, Kubanek B, Levinsky R, Morgan G, Vossen J, Wagemaker G, Landais P. Bone marrow transplantation for immunodeficiencies and osteopetrosis. European Survey 1968–1985. Lancet. 1986; ii: 1080–1083.

    Article  Google Scholar 

  42. Waldmann TA. Ataxia telangiectasia. A multi-system hereditary disease with immunodeficiency, impaired organ maturation, X-ray hypersensitivity, and a high incidence of neoplasia. Ann Intern Med. 1983; 99: 367–379.

    PubMed  CAS  Google Scholar 

  43. Gatti RA. Ataxia-telangiectasia: genetic studies. In: Gupta S, Griscelli C, eds. New Concepts of Immunodeficiency Diseases. Chichester: John Wiley, 1993: 203–229.

    Google Scholar 

  44. Blaese RM, Strober W, Waldmann TA. Immunodeficiency in the Wiskott Aldrich syndrome. In: Bergsma D, Good RA, Finstad J, Paul NW, eds. Immunodeficiency in Man and Animals. Sunderland, USA: Sinauer, 1975: 250–254.

    Google Scholar 

  45. Rosenstein Y, Park JK, Bierer BE, Burakoff SJ. The Wiskott-Aldrich syndrome: An immunodeficiency associated with defects of the CD43 molecule. In: Gupta S, Griscelli C, eds. New Concepts of Immunodeficiency Diseases. Chichester: John Wiley, 1993: 249–268.

    Google Scholar 

  46. Remold-O’Donnell E, Kenney DM, Parkman R, Cairns L, Savage B, Rosen FS. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott Aldrich syndrome. J Exp Med. 1984; 159: 1705–1723.

    Article  PubMed  Google Scholar 

  47. Purtilo DT, Cassel CK, Young JP, Harper R, Stephenson SR, Landing BH, Jawter GF. X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet. 1975; i: 935–940.

    Article  Google Scholar 

  48. Sakamoto K, Freed HJ, Purtilo DT. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. J Immunol. 1980; 125: 921–925.

    PubMed  CAS  Google Scholar 

  49. Sullivan JL, Woda BA. X-linked lymphoproliferative syndrome. In: Rosen FS, Seligman M, eds. Immunodeficiencies. Harwood Academic, 1993: 585–600.

    Google Scholar 

  50. Grossi CE, Crist WM, Abo T, Velardi A, Cooper MD. Expression of the Chediak Higashi lysosomal abnormality in human peripheral blood lymphocyte populations. Blood. 1985; 65: 837–844.

    PubMed  CAS  Google Scholar 

  51. Vilmer E, Lenoir GM, Virelizier JL, Griscelli C. Epstein-Barr serology in immunodeficiencies: an attempt to correlate immune abnormalities in Wiskott Aldrich and Chediak Higashi syndromes and ataxia telangiectasia. Clin Exp Immunol. 1984; 55: 249–256.

    PubMed  CAS  Google Scholar 

  52. Pinching AJ, ed. AIDS and HIV infection. Clin Immunol Allergy. London: WB Saunders; 1986; 6: 467–558.

    Google Scholar 

  53. Clerici M, Shearer GM. A TH1 -* TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993; 14: 107–111.

    Article  PubMed  CAS  Google Scholar 

  54. Eales LJ, Moshtael O, Pinching AJ. Microbicidal activity of monocyte derived macrophages in AIDS and related disorders. Clin Exp Immunol. 1987; 67: 227–235.

    PubMed  CAS  Google Scholar 

  55. Hawkins RE, Rickman LS, Vermund SH, Carl M. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood. J Infect Dis. 1992; 165: 581–585.

    Article  PubMed  CAS  Google Scholar 

  56. Lachmann PJ. Complement. In: McGee JO’D, Isaacson PG, Wright NA, eds. Oxford Textbook of Pathology. Vol. 1. Oxford: Oxford University Press, 1993: 259–266.

    Google Scholar 

  57. Rother K. Summary of reported deficiencies. In: Rother K, Rother U, eds. Hereditary and Acquired Complement Deficiencies in Animals and Man. Basel: Karger, 1986: 202–211.

    Google Scholar 

  58. Winkelstein JA, Shin HS, Wood WB Jr. Heat labile opsonins to pneumococcus. III. The participation of immunoglobulin and of the alternate pathway of C3 activation. J Immunol. 1972; 108: 1681–1689.

    PubMed  CAS  Google Scholar 

  59. Lambris JD. The multi-functional role of C3, the third component of complement. Immunol Today. 1988; 9: 387–393.

    Article  PubMed  CAS  Google Scholar 

  60. Cooper NR. Immune adherence by the fourth component of complement. Science. 1969; 165: 396–398.

    Article  PubMed  CAS  Google Scholar 

  61. Ward PA, Cochrane CG, Müller-Eberhard NJ. The role of serum complement in chemotaxis of leukocytes in vitro. J Exp Med. 1965; 122: 327–346.

    Article  PubMed  CAS  Google Scholar 

  62. Würzner R, Orren A, Lachmann PJ. Inherited deficiencies of the terminal components of human complement. In: Rosen FS, Seligmann M, eds Immunodeficiencies. Harwood Academic, 1993: 295–312.

    Google Scholar 

  63. Haeney MR, Thompson RA, Faulkner J, Mackintosh P, Ball AP. Recurrent bacterial meningitis in patients with genetic defects of terminal complement components. Clin Exp Immunol. 1980; 40: 16–24.

    PubMed  CAS  Google Scholar 

  64. Levy J, Schlesinger M. Complement deficiency: C7, C8 and properdin. In: Gupta S, Griscelli C, eds. New Concepts in Immunodeficiency Diseases. Chichester: John Wiley, 1993: 269–292.

    Google Scholar 

  65. Lint TF, Gewurz H. Component deficiencies–the ninth component. In Rother K, Rother U, eds. Hereditary and Acquired Complement Deficiencies in Animals and Man. Basel: Karger, 1986: 307–310.

    Google Scholar 

  66. Griffiss JM, Bertram MA. Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of invasive disease. J Infect Dis. 1977; 136: 733–739.

    Article  PubMed  CAS  Google Scholar 

  67. Thompson RA, Lachmann P.I. A second case of human C3b inhibitor (KAF) deficiency. Clin Exp Immunol. 1977; 27: 23–39.

    PubMed  CAS  Google Scholar 

  68. Vetrie DF, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarström, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature. 1993; 361: 226–233.

    Article  PubMed  CAS  Google Scholar 

  69. Hermaszewski RA, Webster ADB. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med. 1993; 86: 31–42.

    PubMed  CAS  Google Scholar 

  70. Spickett GP, Webster ADB, Farrant J. Cellular abnormalities in common variable immunodeficiency. In: Rosen FS, Seligmann M, eds. Immunodeficiencies. Philadelphia, PA: Harwood Academic, 1993: 111–126.

    Google Scholar 

  71. Murphy TF, Apicella MA. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens and the human immune response to infection. Rev Infect Dis. 1987; 9: 1–15.

    Article  PubMed  CAS  Google Scholar 

  72. Lever AML, Gross J, Webster ADB. Serum factors for opsoniozation of non-typable H. influenzae. J Clin Microbiol. 1985; 20: 33–38.

    CAS  Google Scholar 

  73. Stroud RM, Nagaki K, Pickering RJ, Gewurz H, Good RA, Cooper MD. Sub-units of the first complement component in immunologic deficiency syndromes. Independence of C1s and Clq. Clin Exp Immunol. 1970; 7: 133–137.

    PubMed  CAS  Google Scholar 

  74. Ahnen DJ, Brown WR. Campylobacter enteritis in immune-deficient patients. Ann Intern Med. 1982; 96: 187–188.

    PubMed  CAS  Google Scholar 

  75. Klipstein FA, Engert RF, Short H, Schenk EA. Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations. Infect Immunity. 1985; 50: 43–49.

    CAS  Google Scholar 

  76. Bernatowska E, Jose P, Davies H, Stephenson M, Webster D. Interaction of campylobacter species with antibody, complement and phagocytes. Gut. 1989; 30: 906–911.

    Article  PubMed  CAS  Google Scholar 

  77. Goodwin CS, Worsley B. Peptic ulcer disease and Helicobacter pylori infection. Curr Opin Gastroenterol. 1992; 8: 122–127.

    Google Scholar 

  78. Forsythe SJ, Dolby JM, Webster ADB, Cole JA. Nitrate-and nitrite-reducing bacteria in the achlorhydric stomach. J Med Microbiol. 1988; 25: 253–259.

    Article  PubMed  CAS  Google Scholar 

  79. Griffiss JM. Biologic function of the serum IgA system: modulation of complement mediated affector mechanisms and conservation of antigenic mass. Ann NY Acad Sci. 1983; 409: 697–707.

    Article  PubMed  CAS  Google Scholar 

  80. Belosevic M, Faubert GM, Dharampaul S. Antimicrobial action of antibodies against Giardia muris trophozoites. Clin Exp Immunol. 1994; 95: 485–489.

    Article  PubMed  CAS  Google Scholar 

  81. Sloper KS, Dourmashkin PR, Bird RB, Slavin G, Webster ADB. Chronic malabsorption due to cryptosporidiosis in a child with immunoglobulin deficiency. Gut. 1982; 23: 80–82.

    Article  PubMed  CAS  Google Scholar 

  82. Korthäuer U, Graf D, Mages HW, Brière F, Munoreedevi P, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature. 1993; 361: 539–543.

    Article  PubMed  Google Scholar 

  83. Unger BLP, Ward DJ, Fayer R, Quinn CA. Cessation of cryptosporidium associated diarrhoea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune colostrum. Gastroenterology. 1990; 58: 2962–2965.

    Google Scholar 

  84. Taylor-Robinson D, McCormack WM. The genital mycoplasmas. N Engl J Med. 1980; 302: 1003–10, 1063–1067.

    Google Scholar 

  85. Roifman CM, Rao CP, Lederman HM, Lavi S, Quinn P, Gelfand EW. Increased susceptibility to mycoplasma infection in patients with hypogammaglobulinaemia. Am J Med. 1986; 80: 590–594.

    Article  PubMed  CAS  Google Scholar 

  86. Webster ADB, Furr PM, Hughes-Jones NC, Gorick BD, Taylor-Robinson D. Critical dependence on antibody for defence against mycoplasmas. Clin Exp Immunol. 1988; 71: 383–387.

    PubMed  CAS  Google Scholar 

  87. McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987; 9: 334–356.

    Article  PubMed  Google Scholar 

  88. Webster ADB. Echovirus disease in hypogammaglobulinaemia patients. Clin Rheum Dis. 1984; 10: 189–203.

    PubMed  CAS  Google Scholar 

  89. Erlendsson K, Swartz T, Dwyer JM. Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinaemia by intraventricular administration of immunoglobulin. N Engl J Med. 1985; 312: 351–353.

    Article  PubMed  CAS  Google Scholar 

  90. Cserr HF, Knopf PM. Cervical lymphatics, the blood—brain barrier and the immunoreactivity of the brain; a new view. Immunol Today. 1992; 13: 507–512.

    Article  PubMed  CAS  Google Scholar 

  91. Webster ADB, Rotbart HA, Warner T, Rudge P, Hyman N. Diagnosis of enterovirus brain disease in hypogammaglobulinemic patients by polymerase chain reaction. Clin Infect Dis. 1993; 17: 657–661.

    Article  PubMed  CAS  Google Scholar 

  92. Wyatt HV. Poliomyelitis in hypogammaglobulinaemia. J Infect Dis. 1973; 128: 802–806.

    Article  PubMed  CAS  Google Scholar 

  93. Hanson LA, Björkander J, Söderström R, Söderström T. Clinical significance of IgG subclass and IgA deficiency. In: Webster ADB, ed. Immunodeficiency and Disease. London: Kluwer Academic, 1988: 99–111.

    Chapter  Google Scholar 

  94. Scadding GK, Lund VJ, Darby YC, Navas-Romero J, Seymour N, Turner MW. IgG subclass levels in chronic rhinosinusitis. Rhinology. 1994; 32: 15–19.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. D. B. Webster
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, University of Cambridge, Cambridge, UK

    J. G. P. Sissons

  2. Department of Medicine, University of Wales, College of Medicine, Cardiff, UK

    L. K. Borysiewicz

  3. Department of Infectious Diseases and Bacteriology, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK

    J. Cohen

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Webster, A.D.B. (1994). The Pattern of Infection in Immunodeficiency. In: Sissons, J.G.P., Borysiewicz, L.K., Cohen, J. (eds) Immunology of Infection. Immunology and Medicine Series, vol 25. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1430-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1430-1_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4626-8

  • Online ISBN: 978-94-011-1430-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation